News Center
We are pleased to announce the signing of an agreement on March 11, 2025, to acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A. This unit focuses on diagnostics, cellular and molecular biology as well as genome analysis and distributes our GenDx line of products in Italy. These strategic acquisitions strengthen […]
As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of 𝐄𝐧𝐝𝐨𝐏𝐫𝐞𝐝𝐢𝐜𝐭® and 𝐏𝐫𝐨𝐥𝐚𝐫𝐢𝐬® in Italy. This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new
Il Gruppo Eurobio Scientific ha completato con successo l'acquisizione di Quimark SRL Read More »
Eurobio Scientific has signed a strategic agreement with Biovica, a company specializing in cancer monitoring, to distribute DiviTum® TKa in key European markets, including DACH, UK, FR and Benelux. This collaboration covers 60% of the European market potential and strengthens Eurobio Scientific’s oncology diagnostics offering. DiviTum® TKa is a blood-based biomarker test that monitors and predicts
La presente Informativa sulla privacy informa l'utente sulle modalità con cui Eurobio Scientific raccoglie e tratta i dati personali che lo riguardano attraverso il proprio sito web www.eurobio-scientific.com (di seguito il Sito) in qualità di titolare del trattamento ai sensi delle disposizioni del Regolamento generale sulla protezione dei dati n. 2016/679 del 27 aprile 2016 ("GDPR") e della Legge sulla protezione dei dati n. 78-17 del 6 gennaio 1978 (di seguito, insieme, i "Regolamenti").